Abacavir - PDFSEARCH.IO - Document Search Engine

Abacavir
Results: 211

#	Item
81	Pour diffusion immediate ViiV Soins de santé obtient l’homologation de TriumeqMC (dolutégravir-abacavir-lamivudine), un nouveau schéma posologique à comprimé unique et à prise uniquotidienne pour le traitement d Add to Reading List Source URL: www.gsk.ca Language: French - Date: 2014-10-15 16:54:51
82	For Immediate Release ViiV Healthcare receives approval for Triumeq™ (dolutegravir/abacavir/lamivudine), in Canada - a new once-daily single-pill regimen for the treatment of HIV Laval (October 14th, 2014) – ViiV He Add to Reading List Source URL: www.gsk.ca Language: English - Date: 2014-10-15 16:53:45 Health Fixed dose combination Chemistry GlaxoSmithKline Pandemics Abacavir/lamivudine Lamivudine Abacavir Antiretroviral drug HIV/AIDS Organofluorides Medicine
83	FDA Patient Safety News: Show #77, July 2008 Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Pharmacology Purines Pharmaceutical industry United States Public Health Service MedWatch Heparin Abacavir Adverse effect Medicine Food and Drug Administration Health
84	Pharmacy & Therapeutics Committee Meeting Add to Reading List Source URL: www.passporthealthplan.com Language: English - Date: 2014-10-16 11:00:28 Cyclopropanes Purines Organic chemistry Lamivudine Cinacalcet Pharmacology Chemistry Abacavir
85	FDA Patient Safety News: Show #81, November 2008 Add to Reading List Source URL: www.fda.gov Language: English Food and Drug Administration Monoclonal antibodies Merck Pharmaceutical industry Immunosuppressants Abacavir Amiodarone Exenatide Simvastatin Pharmacology Chemistry Medicine
86	FDA Patient Safety News: Show #20, October 2003 Add to Reading List Source URL: www.fda.gov Language: English Latent tuberculosis Pyrazinamide Cochlear implant Abacavir Olanzapine Rifampicin Food and Drug Administration Patient safety Tuberculosis treatment Medicine Tuberculosis Health
87	Report of the Medicines Patent Pool Expert Advisory Group on the Proposed Paediatric Collaboration with ViiV Healthcare Introduction Add to Reading List Source URL: www.medicinespatentpool.org Language: English - Date: 2013-02-27 08:18:08 Business Intel Viiv Medicine GlaxoSmithKline Abacavir Lamivudine Patent Pfizer Unitaid Intellectual property law Patent law Law
88	Abacavir Form of Sublicence Add to Reading List Source URL: www.medicinespatentpool.org Language: English - Date: 2013-06-26 08:36:28 Business Know-how Intel Viiv License Royalties Abacavir ViiV Healthcare Trademark Patent Intellectual property law Law Civil law
89	PDF Document Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-04-21 16:03:04 Purines Cyclopropanes Organofluorides Bristol-Myers Squibb Antivirals Abacavir Lamivudine Fixed-dose combination Reverse-transcriptase inhibitor Chemistry Organic chemistry Pharmacology
90	--------------------- DOSAGE FORMS AND STRENGTHS --------------------Tablets: 600 mg of abacavir, 50 mg of dolutegravir, and 300 mg of lamivudine. (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include Add to Reading List Source URL: www.gsksource.com Language: English - Date: 2014-12-03 00:15:28 Chemistry Organic chemistry Fixed dose combination Pharmacology Organofluorides Purines Abacavir Cyclopropanes

UPDATE